Strides Pharma Science Limited has received formal confirmation regarding the processing of security dematerialization and rematerialization requests for the quarter ended March 31, 2026. The company’s Registrar and Share Transfer Agent, KFin Technologies Limited, has successfully verified these activities and confirmed that all required information has been disseminated to the relevant depositories and stock exchanges in accordance with established procedural guidelines.
Quarterly Securities Processing Update
Strides Pharma Science Limited has finalized its compliance reporting for the fourth quarter of the financial year, covering the period ending March 31, 2026. The company, in coordination with its registrar, KFin Technologies Limited, has completed the verification process for all securities-related transactions involving dematerialization and rematerialization.
Verification by Share Transfer Agent
As part of the routine administrative cycle, KFin Technologies Limited confirmed that it has effectively processed all requests received from shareholders. This ensures that the records held by the National Securities Depository Limited (NSDL) and the Central Depository Services (India) Limited (CDSL) are accurate and up-to-date. The relevant data has been duly furnished to all stock exchanges where the company’s equity shares are listed, maintaining transparency in market operations for the quarter.
Source: BSE
